NEWLY DIAGNOSED
If you have been NEWLY DIAGNOSED START HERE
VIDEO LIBRARIES
We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to patients with experience in...
We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to patients with experience in...
We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to patients with experience in...
We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to patients with experience in...
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video series, we are pleased to work...
ARTICLES
We are excited to launch our second year of this exciting program - Patient Perspectives - Clinical Trials Experiences Through Storytelling GRACE’s...
Join us on SATURDAY, JULY 16th, 2022, for the 2022 Targeted Therapies Patient Forum This virtual program is presented Live Online from 10 AM - 4 PM...
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging...
COMMUNITY FORUM
We are excited to launch our second year of this exciting program - Patient Perspectives - Clinical Trials Experiences Through Storytelling GRACE’s...
I have NSCLC and have been off any treatment for a year after developing scarring and interstitial complications. My lung CTs have been stable but my...
In order to help prepare as many people as possible to be educated members of their own cancer care team, Grace is having its annual Targeted...
In order to help prepare as many people as possible to be educated members of their own cancer care team, Grace is having its annual Targeted...
In order to help prepare as many people as possible to be educated members of their own cancer care team, Grace is having its annual Targeted...